The global burden of epilepsy

Area of Science:

• Public Health
• Neurology
• Psychiatry
• Epidemiology

Background:

• The Global Burden of Diseases (GBD) study provides critical insights into population health.
• There is a recognized need for evolving health indicators, moving from mortality to disability measures.
• Neurologic and psychiatric disorders represent a substantial global health challenge.

Purpose of the Study:

• To describe the GBD study's goals and outcomes concerning neurologic and psychiatric disorders.
• To explain the significance of Disability Adjusted Life Years (DALYs) as a health indicator.
• To introduce the World Health Organization's (WHO) ICF framework for functioning and disability.

Main Methods:

• Review of the Global Burden of Diseases (GBD) study methodologies and findings.
• Explanation of the Disability Adjusted Life Years (DALYs) metric.
• Overview of the World Health Organization's Classification of Functioning, Disability and Health (ICF).

Main Results:

• Neurologic and psychiatric disorders contribute significantly to the global disease burden.
• Epilepsy's burden is substantial, accounting for approximately 0.5% of the global disease burden in 2000.
• The shift towards disability indicators, exemplified by the WHO World Health Report 2001, is crucial for understanding conditions like epilepsy.

Conclusions:

• The GBD study and the WHO ICF framework offer improved tools for assessing and addressing global health issues.
• Despite increased recognition, epilepsy requires greater prioritization as a public health concern.
• Understanding and addressing the disability burden of epilepsy is essential for global health agendas.